ALTO-100 in Bipolar Disorder With Depression (BD-D)

Clinical trial NCT06656416 · RECRUITING

Trial details

NCT number: NCT06656416
Sponsor: Alto Neuroscience
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bipolar Disorder I or II With a Major Depressive Episode

Start date: 2024-10-02
Primary completion: 2026-08-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.